Effects of Canakinumab On The Progression of Type 1 Diabetes In New Onset Subjects.
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Canakinumab (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TrialNet
- 07 Jun 2017 Biomarkers information updated
- 08 Apr 2013 Results published in the Lancet.
- 05 Apr 2013 Primary endpoint 'C-peptide-levels' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History